Sep 07, 2022 / 01:40PM GMT
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - Director
(technical difficulty)
excellent CEOs from cell therapy companies across the United States. Pascal Touchon from Atara; Nick Leschly, 2seventy bio; and Andre Choulika from Cellectis. Welcome, everyone. Thank you so much for joining.
Questions and Answers:
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - DirectorSo maybe just to start, if each of you could spend 2 or 3 minutes just giving a high-level overview of your company and what are the strengths and differentiating qualities for each of your cell therapy platforms, and then we can go into more specifics after that. So you want to start, Pascal?
Pascal Touchon - Atara Biotherapeutics, Inc. - President, CEO & Director
Yes. Pleasure. Thank you for inviting us to this panel. Atara Bio is a leading company in the field of allogeneic cell therapy, developing transformative therapies for patients in need in both oncology and autoimmune disease. In fact, we are leveraging